Zoetis Opens New R&D Facility In North Carolina




Today, Zoetis, the world leader in Animal Health, marked the official opening of its new building dedicated to diagnostics and biodevices research and development with a ribbon cutting ceremony at its site in Durham, N.C.

The ceremony was attended by local officials, including North Carolina Secretary of Commerce Machelle Baker Sanders, North Carolina Representative Zack Hawkins and key company leaders including Zoetis CEO Kristin Peck, and President of Research and Development Rob Polzer.

The expanded site serves as the hub for Zoetis' engineering and diagnostics work including device reliability testing. The new building features more than 78,000 square feet including 23,000 square feet of total lab space allotted for a biodevice engineering lab, biodevice science lab, diagnostics engineering lab and diagnostics engineering lab space.
Zoetis has added 54 jobs to its diagnostics and biodevices research and development team in Durham in the last three years.

ZOETIS IN DURHAM

Zoetis' site in Durham, N.C., is a crucial part of the company's global research and development locations around the world. It serves as the company's R&D hub for diagnostics and engineering capabilities.

Zoetis employs approximately 200 people at its site in Durham, more than half of whom are dedicated to the company's R&D work. Other colleagues on site are dedicated to U.S. Poultry, Global BioDevices commercial operations, as well as related manufacturing and enabling functions.

Zoetis, and before that Embrex, has had a presence in Durham, N.C., for more than 30 years.

Source: Zoetis news release